High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
Abstract Introduction OX-40 co-stimulatory signaling plays a role in mounting anti-tumor immune responses and clinical trials targeting this pathway are ongoing. However, the association of with OX-40 protein expression with clinical outcomes and pathological features in non-small cell lung cancer (...
Main Authors: | Erminia Massarelli, Vincent K. Lam, Edwin R. Parra, Jaime Rodriguez-Canales, Carmen Behrens, Lixia Diao, Jing Wang, Jorge Blando, Lauren A. Byers, Niranjan Yanamandra, Sara Brett, Peter Morley, Padmanee Sharma, James Allison, Ignacio I. Wistuba, John V. Heymach |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-12-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0827-2 |
Similar Items
-
Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism
by: Q. Dong, et al.
Published: (2013-09-01) -
OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
by: Deng J, et al.
Published: (2019-09-01) -
The OX40/OX40L Axis Regulates T Follicular Helper Cell Differentiation: Implications for Autoimmune Diseases
by: NanNan Fu, et al.
Published: (2021-06-01) -
The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis
by: Julie Sophie Elsner, et al.
Published: (2020-03-01) -
The pharmacokinetics of inhaled anaesthetics in the sheep and ox
by: Pearson, M. R. B.
Published: (1988)